Stran & Company, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Income (Loss) Per Share (Tables)

Income (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2026

Schedule of Basic and Diluted Net Income Per Share of Common Stock

The following tables set forth the computation of basic and diluted net income (loss) per share of common stock for the three and nine months ended September 30, 2026:

	Three Months Ended September 30, 2026		Nine Months Ended September 30, 2026
Basic net income per common share:
Numerator:
Net income	$	35	$	1,088
Denominator:
Weighted average number of shares of common stock outstanding		18,598,888		18,651,811
Basic net income per common share	$	0.00	$	0.06

Diluted net income per common share:
Numerator:
Net income	$	35	$	1,088
Denominator:
Number of shares used in basic computation		18,598,888		18,651,811
Add: effect of dilutive securities:
Stock options		26,243		27,264
Weighted average number of shares of common stock outstanding used to calculate diluted income per share		18,625,131		18,679,075
Diluted net income per common share	$	0.00	$	0.06

Schedule of Diluted Net Income (Loss) Per Share

The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the computation of diluted net income (loss) per share for the periods presented because their inclusion would have been anti-dilutive.

	For the Three Months Ended September 30, 2026		For the Nine Months Ended September 30, 2026		For the Three and Nine Months Ended September 30, 2025
Warrants		10,074,195		10,074,195		10,074,195
Stock options		1,263,500		1,263,500		1,410,499
		11,337,695		11,337,695		11,484,694